Ocugen Inc (OCGN) support and resistance · rev $3.0M
Ocugen Inc (OCGN) is a biotechnology company listed on NASDAQ.
This page maps Ocugen Inc (OCGN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported OCGN revenue for 2026-06-30 was $3.0M. Net income was -$44.1M. Revenue was up 97.1% from 2026-03-31 to 2026-06-30. OCGN currently screens at market cap $416.4M.
OCGN currently screens at market cap $416.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new OCGN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the OCGN quote page for the session range and the stock page for the full model.
Not investment advice.